Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT03495193
Eligibility Criteria:
Inclusion Criteria:
* a clinical diagnosis of idiopathic PD, based on the presence of bradykinesia as well as rest tremor and/or rigidity;
* Hoehn and Yahr stage 2-3;
* age ≥ 45;
* on stable medications for at least 4 weeks prior to study entry;
* Participants must have Montreal Cognitive Assessment (MoCA) score ≥ 18;
* No contraindications to an exercise program, based on the Physical Activity Readiness Questionnaire (PAR-Q), resting physical examination, and 12-lead electrocardiogram.
Exclusion Criteria:
* features suggestive of atypical Parkinsonism (cerebellar signs, supranuclear gaze palsy, prominent autonomic failure, or prominent upper motor neuron signs);
* secondary Parkinsonism (multiple strokes with stepwise progression of Parkinsonism, neuroleptic treatment at time of diagnosis, or multiple head injuries);
* inability to walk without a cane or walker;
* regular participation in an exercise program in the past 6 months;
* presence of deep brain stimulator; and
* untreated sleep apnea.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT03495193
Study Brief:
Protocol Section:
NCT03495193